Boiler, you absolutely crack me up.
You started by incorrectly contradicting Nuts about the placebo arm of the CAN004 trial. Got shot down.
Then post references to trials that have nothing to do with Cvac and asked the question
"Don't you need to successfully pass through a Phase 2 before you can commence Phase 3"
Answer: No, you can go straight from Phase 1 to Phase 3 if the FDA approves the trial. Look it up! Strike 2
Switch to Plan B. Since the US trials information doesn't help you pull your pant back up, try and confuse the issue by referencing the EU trials website. Yes, a significant number of the Canvas trial sites are in Europe and the data obtained fom them will be collected and incorporated into the final results that will go to.....wait for it....the USFDA for approval.
The company has always said it intends to seek commercial approval in the USA first, then Eu.
As you say, you're entitled to post whatever you like, but since you have no financial tie to the company, why are you continuing to "waste your time" trying to dig up any bit of dross to cause confusion?
Case in point is you continuing to sarcastically refer to the "software issue", as if you don't accept that is precisely what it was...as confirmed by the CEO and sorted out exactly as he indicated it would be. Grown ups usually admit when they've been convincingly proved wrong.
Keep posting whatever you want, I have plenty of free time to point out where you've gone astray.
- Forums
- ASX - By Stock
- IMM
- another good night on nasdaq
another good night on nasdaq, page-56
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $465.4M |
Open | High | Low | Value | Volume |
32.0¢ | 33.0¢ | 31.8¢ | $845.3K | 2.621M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 140318 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 14222 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 140318 | 0.315 |
11 | 236106 | 0.310 |
17 | 282515 | 0.305 |
22 | 424323 | 0.300 |
5 | 79251 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 14222 | 1 |
0.325 | 61530 | 3 |
0.330 | 244628 | 4 |
0.335 | 85951 | 4 |
0.340 | 120063 | 4 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online